Health ❯Healthcare ❯Vaccines

Covid-19 Vaccines

mRNA Vaccines Novavax Vaccine Moderna Covid Vaccine Market Competition Comirnaty FDA Recommendations Eligibility Criteria Booster Shots Novavax Covid Vaccine Moderna

Moderna’s Combined COVID-19 and Flu Vaccine Shows Promising Phase III Results

Phase III trial data published in JAMA confirms the vaccine's safety and efficacy, but regulatory approval and strain updates are pending.

Moderna Reports Larger-Than-Expected Q4 Loss as COVID Vaccine Sales Plummet

Pfizer Exceeds Q4 Earnings Expectations with Strong Covid Product Sales and Cost Cuts

Moderna Cuts 2025 Revenue Forecast by $1 Billion, Shares Drop Over 20%

Moderna Stock Surges After Bird Flu Vaccine Developments and Rising Respiratory Illness Rates

FDA Authorizes New Novavax Vaccine Targeting Omicron Variant

Moderna Lowers Annual Sales Forecast Amid Competitive Vaccine Market